← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 31, 2018Last known activity
Nov 2, 2020
Acquired by Merck on Jan 8, 2024
Timeline
2010s
- Jun 1, 2015
Harpoon Therapeutics— Founded
2020s
- Jan 8, 2024
Merck— Acquired By
Drugs by trial phase (4 distinct, 4 trials)
Indications
Recent trials (4)
- NCT04471727Lead sponsorPhase 1/Phase 2Nov 2, 2020
- NCT04184050Lead sponsorPhase 1/Phase 2Jan 2, 2020
- NCT03872206Lead sponsorPhase 1/Phase 2Apr 16, 2019
- NCT03577028Lead sponsorPhase 1Jul 31, 2018
Details
- Founded
- South San Francisco, CA, US Jun 1, 2015
- Last known activity
- Nov 2, 2020